Application of low-intensity anticoagulation after On-X mechanical aortic valve replacement
Journal of Cardiothoracic Surgery · 2025
DOI: 10.1186/s13019-024-03215-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiothoracic Surgery, 2025. Verfasst von Kun Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Nuclear Technology Medical Transformation(MIANYANG CENTRAL HOSPITAL), Mianyang, Sichuan Province, 621000, China. Hauptthemen laut MEDLINE: Anticoagulants, Aortic Valve, Heart Valve Prosthesis Implantation. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Sichuan Province, Clinical Translation Research of Sichuan Provincial People's Hospital, Clinical Translation Research of Sichuan Provincial People’s Hospital.
Abstract (Originalsprache)
OBJECTIVE: To explore the safety and efficacy of low-intensity anticoagulation in patients after On-X mechanical aortic valve replacement. METHODS: A total of 104 patients undergoing aortic valve replacement in Cardiac Surgery Department of Sichuan Provincial People's Hospital from December 2018 to December 2021 were randomly divided into low-intensity anticoagulant (INR:1.5-2.0) and high-intensity anticoagulant (INR:2.0-2.5) to compare the incidence of adverse events related to postoperative anticoagulation between the two groups. RESULTS: Fifty-three patients were included in the low-intensity anticoagulation group (INR 1.5-2.0), and 51 patients were included in the high-intensity group (2.0-2.5). There was no significant difference in baseline data and surgical index between the two groups (P > 0.05); there were statistically significant differences in PT, INR and bleeding events (P 0.05). CONCLUSION: For patients requiring On-X mechanical aortic valve replacement who have no risk factors for thromboembolism, it is appropriate to control the INR in the target range 1.5-2.0, which can reduce the incidence of bleeding adverse events and significantly improve the quality of life, without increasing the risk of thromboembolic adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Nuclear Technology Medical Transformation(MIANYANG CENTRAL HOSPITAL), Mianyang, Sichuan Province, 621000, China.
- Cardiac Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan Province, 610072, China.
- Cardiac Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan Province, 610072, China. liusq…
Förderung
- Natural Science Foundation of Sichuan Province
- Clinical Translation Research of Sichuan Provincial People's Hospital
- Clinical Translation Research of Sichuan Provincial People’s Hospital
Zitieren
APA
Zou, K., Wei, D., Xiang, B., Yu, T., Huang, K., & Liu, S. (2025). Application of low-intensity anticoagulation after On-X mechanical aortic valve replacement. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-024-03215-7
Vancouver
Zou K, Wei D, Xiang B, Yu T, Huang K, Liu S. Application of low-intensity anticoagulation after On-X mechanical aortic valve replacement. Journal of Cardiothoracic Surgery. 2025. doi:10.1186/s13019-024-03215-7
BibTeX
@article{Zou2025,
author = {Zou, Kun and Wei, Dachuang and Xiang, Bo and Yu, Tao and Huang, Keli and Liu, Shengzhong},
title = {Application of low-intensity anticoagulation after On-X mechanical aortic valve replacement},
journal = {Journal of Cardiothoracic Surgery},
year = {2025},
doi = {10.1186/s13019-024-03215-7}
}
EUVIMED